Total number of projects: 1
As coordinator: 1
As participant: 0
Sole participant: 0
Coordinator / Participant Ratio: *
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 9.902.750 | 0 | 6.558.750 | 1 |
Institution: | Projects [No]: |
---|---|
GRANZER HEINZ ULRICH | 1 |
MILLIPORE SAS | 1 |
VIB VZW | 1 |
Total number of partners: 3
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 3
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-12-01 | ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2 | XVR011 Phase 2 | coordinator | 9.902.750 | 4 |